Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ
Abstract Background Tumour-infiltrating lymphocytes (TILs) have been demonstrated to significantly influence prognosis and response to therapy of invasive breast cancer (IBC). Thus, it has been suggested that TIL density or/and immunophenotype could serve as biomarkers for selection of IBC patients...
Main Authors: | Marie Beguinot, Marie-Melanie Dauplat, Fabrice Kwiatkowski, Guillaume Lebouedec, Lucie Tixier, Christophe Pomel, Frederique Penault-Llorca, Nina Radosevic-Robin |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-02-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-018-4013-6 |
Similar Items
-
Diagnostic pitfall in a case of ductal carcinoma-in situ with microinvasion
by: Yasmin A Momin, et al.
Published: (2016-01-01) -
Ductal Carcinoma In Situ (DCIS) and Microinvasive DCIS: Role of Surgery in Early Diagnosis of Breast Cancer
by: Francesca Magnoni, et al.
Published: (2023-05-01) -
Clinicopathological features and prognostic differences of ductal carcinoma in situ with ductal carcinoma in situ with microinvasion
by: LIU Jing, et al.
Published: (2020-07-01) -
A clinical radiomics nomogram preoperatively to predict ductal carcinoma in situ with microinvasion in women with biopsy-confirmed ductal carcinoma in situ: a preliminary study
by: Zhou Huang, et al.
Published: (2023-09-01) -
Different distribution of breast ductal carcinoma <it>in situ</it>, ductal carcinoma <it>in situ</it> with microinvasion, and invasion breast cancer
by: Wei Zhang, et al.
Published: (2012-12-01)